Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joseph Schwartz is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.62 | — | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/24/2024 | SLDB | Buy Now | Solid Biosciences | $6.75 | 77.78% | $12 → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 06/20/2024 | MREO | Buy Now | Mereo BioPharma Group | $3.56 | 124.72% | $6 → $8 | Maintains | Outperform | Get Alert |
| 03/18/2024 | RGLS | Buy Now | Regulus Therapeutics | $1.65 | 263.5% | → $6 | Initiates | → Outperform | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.57 | 253.36% | $9 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | APLT | Buy Now | Applied Therapeutics | $4.86 | 146.91% | → $12 | Initiates | → Outperform | Get Alert |
| 02/13/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.62 | 167.18% | $23 → $7 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/09/2024 | SYBX | Buy Now | Synlogic | $1.53 | -34.64% | → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/15/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | $1.47 | -31.97% | → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/08/2023 | SPRB | Buy Now | Spruce Biosciences | $0.57 | 1490.11% | $3 → $9 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/18/2023 | SELB | Buy Now | Selecta Biosciences | — | — | → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/15/2023 | DSGN | Buy Now | Design Therapeutics | $3.50 | 71.43% | → $6 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/13/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $44 → $40 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/12/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $80 → $115 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/17/2023 | PTCT | Buy Now | PTC Therapeutics | $31.73 | 51.28% | → $48 | Initiates | → Market Perform | Get Alert |
| 02/03/2023 | PHVS | Buy Now | Pharvaris | $16.65 | 8.11% | $20 → $18 | Maintains | Outperform | Get Alert |
| 02/03/2023 | KALV | Buy Now | KalVista Pharma | $12.20 | 63.93% | $30 → $20 | Maintains | Outperform | Get Alert |
| 02/03/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $47.24 | -28.03% | $33 → $34 | Maintains | Market Perform | Get Alert |
| 02/03/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 57.23% | $122 → $130 | Maintains | Outperform | Get Alert |
| 01/20/2023 | SRPT | Buy Now | Sarepta Therapeutics | $151.47 | 5.63% | → $160 | Reiterates | → Outperform | Get Alert |
| 01/17/2023 | ASND | Buy Now | Ascendis Pharma | $136.46 | 19.45% | $148 → $163 | Maintains | Outperform | Get Alert |
| 12/27/2022 | AMTI | Buy Now | Applied Molecular | — | — | $15 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/09/2022 | DSGN | Buy Now | Design Therapeutics | $3.50 | 528.57% | $30 → $22 | Maintains | Outperform | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.15 | 769.57% | $15 → $10 | Maintains | Outperform | Get Alert |
| 11/14/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 8.46% | $168 → $148 | Maintains | Outperform | Get Alert |
| 11/14/2022 | ANTX | Buy Now | AN2 Therapeutics | $2.62 | 854.2% | $27 → $25 | Maintains | Outperform | Get Alert |
| 11/10/2022 | SLDB | Buy Now | Solid Biosciences | $6.75 | -11.11% | $1 → $6 | Maintains | Market Perform | Get Alert |
| 11/10/2022 | PEPG | Buy Now | PepGen | $16.78 | 96.66% | $40 → $33 | Maintains | Outperform | Get Alert |
| 11/10/2022 | MREO | Buy Now | Mereo BioPharma Group | $3.56 | 12.36% | $8 → $4 | Maintains | Outperform | Get Alert |
| 11/08/2022 | AMTI | Buy Now | Applied Molecular | — | — | $21 → $15 | Maintains | Outperform | Get Alert |
| 11/04/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $5.63 | 113.14% | $17 → $12 | Maintains | Outperform | Get Alert |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 160.3% | $115 → $108 | Maintains | Outperform | Get Alert |
| 10/27/2022 | INSM | Buy Now | Insmed | $70.05 | -28.62% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/20/2022 | TVTX | Buy Now | Travere Therapeutics | $8.72 | 335.78% | $45 → $38 | Maintains | Outperform | Get Alert |
| 10/17/2022 | SLDB | Buy Now | Solid Biosciences | $6.75 | -85.18% | $180 → $15 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/17/2022 | SRPT | Buy Now | Sarepta Therapeutics | $151.47 | -4.27% | $126 → $145 | Maintains | Outperform | Get Alert |
| 10/05/2022 | KALV | Buy Now | KalVista Pharma | $12.20 | 145.9% | $45 → $30 | Maintains | Outperform | Get Alert |
| 09/14/2022 | PHVS | Buy Now | Pharvaris | $16.65 | 20.12% | $25 → $20 | Maintains | Outperform | Get Alert |
| 08/23/2022 | PHVS | Buy Now | Pharvaris | $16.65 | 50.15% | $45 → $25 | Maintains | Outperform | Get Alert |
| 08/11/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 23.11% | $174 → $168 | Maintains | Outperform | Get Alert |
| 08/05/2022 | TVTX | Buy Now | Travere Therapeutics | $8.72 | 416.06% | $42 → $45 | Maintains | Outperform | Get Alert |
| 08/05/2022 | CCXI | Buy Now | ChemoCentryx | — | — | $64 → $52 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/04/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 47.56% | $115 → $122 | Maintains | Outperform | Get Alert |
| 07/08/2022 | KALV | Buy Now | KalVista Pharma | $12.20 | 268.85% | $51 → $45 | Maintains | Outperform | Get Alert |
| 06/06/2022 | SELB | Buy Now | Selecta Biosciences | — | — | → $7 | Initiates | → Outperform | Get Alert |
| 05/31/2022 | PEPG | Buy Now | PepGen | $16.78 | 138.38% | → $40 | Initiates | → Outperform | Get Alert |
| 05/26/2022 | CRNX | Buy Now | Crinetics Pharmaceuticals | $45.40 | -14.1% | $36 → $39 | Maintains | Outperform | Get Alert |
| 05/23/2022 | KDNY | Buy Now | Chinook Therapeutics | — | — | $38 → $44 | Maintains | Outperform | Get Alert |
| 05/20/2022 | AMTI | Buy Now | Applied Molecular | — | — | $60 → $21 | Maintains | Outperform | Get Alert |
| 05/12/2022 | IFRX | Buy Now | InflaRx | $1.61 | 148.45% | $6 → $4 | Maintains | Outperform | Get Alert |
| 05/12/2022 | EWTX | Buy Now | Edgewise Therapeutics | $20.92 | 43.4% | $34 → $30 | Maintains | Outperform | Get Alert |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 27.51% | $193 → $174 | Maintains | Outperform | Get Alert |
| 05/11/2022 | GOSS | Buy Now | Gossamer Bio | $1.15 | 1204.35% | $16 → $15 | Maintains | Outperform | Get Alert |
| 05/11/2022 | RNA | Buy Now | Avidity Biosciences | $38.62 | 29.47% | $53 → $50 | Maintains | Outperform | Get Alert |
| 05/10/2022 | DSGN | Buy Now | Design Therapeutics | $3.50 | 757.14% | $36 → $30 | Maintains | Outperform | Get Alert |
| 05/10/2022 | AMTI | Buy Now | Applied Molecular | — | — | $74 → $60 | Maintains | Outperform | Get Alert |
| 05/06/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 177.18% | $178 → $115 | Maintains | Outperform | Get Alert |
| 05/05/2022 | PTGX | Buy Now | Protagonist Therapeutics | $34.69 | -13.52% | $50 → $30 | Maintains | Outperform | Get Alert |
| 05/03/2022 | QURE | Buy Now | uniQure | $3.78 | 1381.48% | $71 → $56 | Maintains | Outperform | Get Alert |
| 04/28/2022 | SLDB | Buy Now | Solid Biosciences | $6.75 | 122.23% | $180 → $225 | Maintains | Outperform | Get Alert |
| 04/06/2022 | IMRA | Buy Now | Imara | — | — | $124 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/30/2022 | PHVS | Buy Now | Pharvaris | $16.65 | 170.27% | $50 → $45 | Maintains | Outperform | Get Alert |
| 03/25/2022 | IFRX | Buy Now | InflaRx | $1.61 | 272.67% | $8 → $6 | Maintains | Outperform | Get Alert |
| 03/24/2022 | RPHM | Buy Now | Reneo Pharmaceuticals | $1.47 | 920.41% | $25 → $15 | Maintains | Outperform | Get Alert |
| 03/18/2022 | SYBX | Buy Now | Synlogic | $1.53 | 422.88% | $165 → $120 | Maintains | Outperform | Get Alert |
| 03/16/2022 | SPRB | Buy Now | Spruce Biosciences | $0.57 | 430.04% | $5 → $3 | Maintains | Market Perform | Get Alert |
| 03/16/2022 | IMRA | Buy Now | Imara | — | — | $148 → $124 | Maintains | Outperform | Get Alert |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $136.46 | 41.43% | $190 → $193 | Maintains | Outperform | Get Alert |
| 03/08/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $5.63 | 290.76% | $30 → $22 | Maintains | Outperform | Get Alert |
| 02/24/2022 | FOLD | Buy Now | Amicus Therapeutics | $10.17 | 37.66% | $16 → $14 | Maintains | Outperform | Get Alert |
| 02/22/2022 | INSM | Buy Now | Insmed | $70.05 | -25.77% | $57 → $52 | Maintains | Outperform | Get Alert |
| 01/14/2022 | FOLD | Buy Now | Amicus Therapeutics | $10.17 | 57.33% | $12 → $16 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $8.72 | 381.65% | — | Maintains | Outperform | Get Alert |
| 12/14/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/10/2021 | RNA | Buy Now | Avidity Biosciences | $38.62 | 37.23% | — | Maintains | Outperform | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 39.09% | — | Maintains | Outperform | Get Alert |
| 11/16/2021 | SPRB | Buy Now | Spruce Biosciences | $0.57 | 783.39% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/15/2021 | ASND | Buy Now | Ascendis Pharma | $136.46 | 39.23% | — | Maintains | Outperform | Get Alert |
| 11/15/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 35.46% | — | Maintains | Outperform | Get Alert |
| 11/11/2021 | SYBX | Buy Now | Synlogic | $1.53 | 618.95% | — | Maintains | Outperform | Get Alert |
